# Institut Jules Bordet

Source: https://nuclide.cc/institutions/institut-jules-bordet/  
Nuclide record `institut-jules-bordet` (Institution). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)"; commercial use needs a licence.

## TL;DR

Belgium's only hospital devoted entirely to cancer, birthplace of the Breast International Group and a world centre for breast cancer trials.

## Summary

The Institut Jules Bordet opened in 1939, named after the Nobel laureate immunologist Jules Bordet, and moved to a new building beside Erasme Hospital in Anderlecht in 2021 as part of the Hôpital Universitaire de Bruxelles. It is OECI-accredited as a comprehensive cancer centre. Martine Piccart co-founded the Breast International Group here and led the HERA trial of adjuvant trastuzumab; Christos Sotiriou's laboratory developed gene expression signatures for breast cancer and Michail Ignatiadis leads circulating tumour DNA studies, while Ahmad Awada's early-phase unit tests new agents. Bordet is also strong in haematology, nuclear medicine and surgical oncology, and Brussels hosts both BIG and EORTC headquarters.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- Also known as: Jules Bordet Institute; Bordet; Hôpital Universitaire de Bruxelles
- City: Brussels, BE
- Type: cancer-center
- Website: https://www.bordet.be

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Institut_Jules_Bordet
- Homepage: https://www.bordet.be
- Breast International Group: https://www.bigagainstbreastcancer.org

## Connected records

- indications: [Diffuse large B-cell lymphoma](https://nuclide.cc/indications/dlbcl/), [HER2-positive breast cancer](https://nuclide.cc/indications/breast-her2-positive/)
- drugs: [Pembrolizumab](https://nuclide.cc/drugs/pembrolizumab/)

---
JSON: https://nuclide.cc/api/v1/entities/institut-jules-bordet.json